IGI Logo

Strides Pharma Science is currently trading at Rs. 1075.80, up by 36.30 points or 3.49% from its previous closing of Rs. 1039.50 on the BSE.

The scrip opened at Rs. 1027.15 and has touched a high and low of Rs. 1079.00 and Rs. 1027.15 respectively. So far 7973 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1120.30 on 30-Jul-2024 and a 52 week low of Rs. 412.45 on 18-Aug-2023.

Last one week high and low of the scrip stood at Rs. 1100.95 and Rs. 992.00 respectively. The current market cap of the company is Rs. 9895.16 crore.

The promoters holding in the company stood at 25.86%, while Institutions and Non-Institutions held 45.28% and 28.87% respectively.

Strides Pharma Science’s wholly owned subsidiary -- Strides Arcolab International (SAIL UK) is planning to acquire balance stake in Strides Global Consumer Healthcare (Consumer UK) from the existing Investor. 

Consumer UK is an IP holding entity and is into the business of sale and distribution of pharmaceutical and other over-the-counter consumer health care products, through its subsidiaries in US and India. SAIL UK is currently holding 19% stake in Consumer UK. As at March 31, 2024, carrying value of this investment in the books of SAIL UK is NIL. SAIL UK is acquiring the balance 81% stake from the existing Investor at GBP One.

Strides Group has assessed the business opportunity and would like to strengthen its existing portfolio with the CHC Brands which have good recall value. Strides can leverage its relationship with wholesalers in the US and other geographies and advance this business in various territories like US, UK and MENA.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.